RFCA
EW icon

R&F Capital Advisors’s Edwards Lifesciences EW Stock Holding History

R&F Capital Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$951K Buy
+30,324
New +$949K 0.25% 100

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

R&F Capital Advisors's EW Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Edwards Lifesciences (EW) in Q1 2017: 30,324 shares worth $951K. The stake represents 0.25% of the portfolio and ranks #100 among its holdings.

691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • R&F Capital Advisors held 30,324 shares of Edwards Lifesciences worth $951K as of Q1 2017.
  • Edwards Lifesciences was a new R&F Capital Advisors position in Q1 2017.
  • Edwards Lifesciences made up 0.25% of R&F Capital Advisors's portfolio in Q1 2017, its #100 holding.
  • 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.